These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30052955)

  • 1. Treatment strategies for in-stent restenosis in peripheral arterial disease: a systematic review.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Torella F; Antoniou GA
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):253-261. PubMed ID: 30052955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
    J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.
    Armstrong EJ; Thiruvoipati T; Tanganyika K; Singh GD; Laird JR
    J Endovasc Ther; 2015 Aug; 22(4):506-13. PubMed ID: 26130385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.
    Sethi A; Malhotra G; Singh S; Singh PP; Khosla S
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002778. PubMed ID: 26546577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis of percutaneous transluminal atherectomy in the treatment for in-stent restenosis of lower extremity peripheral artery disease].
    Li W; Zhang T; Liu Y; Zhang Y; Li Q; Zhang X; Shen C
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3625-30. PubMed ID: 26813379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
    Shammas NW; Jones-Miller S; Shammas GA; Shammas WJ
    J Invasive Cardiol; 2020 Aug; 32(8):289-294. PubMed ID: 32737264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis.
    Wu R; Li Z; Wang M; Chang G; Yao C; Wang S
    Int J Surg; 2017 Jun; 42():72-82. PubMed ID: 28461145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excimer laser atherectomy in complex peripheral artery disease: a prospective European registry.
    Bürckenmeyer F; Aschenbach R; Diamantis I; Teichgräber U
    J Cardiovasc Surg (Torino); 2021 Apr; 62(2):153-161. PubMed ID: 33480520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherectomy for peripheral arterial disease.
    Ambler GK; Radwan R; Hayes PD; Twine CP
    Cochrane Database Syst Rev; 2014 Mar; (3):CD006680. PubMed ID: 24638972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.
    Krankenberg H; Tübler T; Ingwersen M; Schlüter M; Scheinert D; Blessing E; Sixt S; Kieback A; Beschorner U; Zeller T
    Circulation; 2015 Dec; 132(23):2230-6. PubMed ID: 26446728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role for DCBs in the treatment of ISR.
    Bague N; Nasr B; Chaillou P; Costargent A; Gouailler-Vulcain F; Goueffic Y
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons.
    Van Den Berg JC; Pedrotti M; Canevascini R; Chimchila Chevili S; Giovannacci L; Rosso R
    J Cardiovasc Surg (Torino); 2012 Apr; 53(2):215-22. PubMed ID: 22456644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease.
    Yang X; Lu X; Ye K; Li X; Qin J; Jiang M
    Vasc Endovascular Surg; 2014 Jan; 48(1):18-26. PubMed ID: 24212407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-stent restenosis: mid-term results of debulking using excimer laser and drug-eluting balloons: sustained benefit?
    van den Berg JC; Pedrotti M; Canevascini R; Chimchila Chevili S; Giovannacci L; Rosso R
    J Invasive Cardiol; 2014 Jul; 26(7):333-7. PubMed ID: 24993991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
    Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.
    Idemoto A; Okamoto N; Tanaka A; Mori N; Nakamura D; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Vasc Endovascular Surg; 2017 Jul; 51(5):335-337. PubMed ID: 28486842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.